The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-κB signaling

Apoptosis

Volumn 20, Issue 2, 2015, Pages 174-195

  Kao, Wen Pin ^a   Yang, Chao Yu ^a   Su, Tsung Wei ^a   Wang, Yin Ting ^a   Lo, Yu Chih ^b   Lin, Su Chang ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; CARD; Crystal structure; Inflammation; NF B activation

Indexed keywords

CASPASE 9; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; HETERODIMER; HOMODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; RETINOIC ACID INDUCIBLE PROTEIN I; SMAD5 PROTEIN; UBIQUITIN; DEATH RECEPTOR; PROTEIN BINDING;

APOPTOSIS; ARTICLE; CASPASE RECRUITMENT DOMAIN; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; INFLAMMATION; NONHUMAN; OLIGOMERIZATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SURFACE PROPERTY; CHEMICAL STRUCTURE; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE;

APOPTOSIS; CARD SIGNALING ADAPTOR PROTEINS; HUMANS; INFLAMMATION; MODELS, MOLECULAR; NF-KAPPA B; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

EID: 84922105556     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-014-1062-4     Document Type: Article

References (120)

1. Haanen C, Vermes I (1995) Apoptosis and inflammation. Mediators Inflamm 4:5-15. doi: 10.1155/S0962935195000020
2. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25:561-586. doi: 10.1146/annurev.immunol.25.022106.141656
3. Joshi VD, Kalvakolanu DV, Cross AS (2003) Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis. FEBS Lett 555:180-184
4. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
5. Duvall E, Wyllie AH (1986) Death and the Cell. Immunol Today 7:115-119. doi: 10.1016/0167-5699(86)90152-0
6. Salvesen GS (2002) Caspases and apoptosis. Essays Biochem 38:9-19
7. Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897-907. doi: 10.1038/nrm1496
8. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
9. Fernald K, Kurokawa M (2013) Evading apoptosis in cancer. Trends Cell Biol 23:620-633. doi: 10.1016/j.tcb.2013.07.006
10. Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621-632. doi: 10.1038/nrm2952
11. Lomonosova E, Chinnadurai G (2008) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27(1):S2-S19. doi: 10.1038/onc.2009.39
12. Tait SW, Green DR (2013) Mitochondrial regulation of cell death. Cold Spring Harb perspect biol. doi: 10.1101/cshperspect.a008706
13. Moldoveanu T, Follis AV, Kriwacki RW, Green DR (2014) Many players in BCL-2 family affairs. Trends Biochem Sci 39:101-111. doi: 10.1016/j.tibs.2013.12.006
14. Bao Q, Shi Y (2007) Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 14:56-65. doi: 10.1038/sj.cdd.4402028
15. Shi Y (2006) Mechanical aspects of apoptosome assembly. Curr Opin Cell Biol 18:677-684. doi: 10.1016/j.ceb.2006.09.006
16. Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8:405-413. doi: 10.1038/nrm2153
17. Silke J, Meier P (2013) Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harbor perspectives in biology. doi: 10.1101/cshperspect.a008730
18. Sessler T, Healy S, Samali A, Szegezdi E (2013) Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther 140:186-199. doi: 10.1016/j.pharmthera.2013.06.009
19. Lavrik I, Golks A, Krammer PH (2005) Death receptor signaling. J Cell Sci 118:265-267. doi: 10.1242/jcs.01610
20. Park SM, Schickel R, Peter ME (2005) Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 17:610-616. doi: 10.1016/j.ceb.2005.09.010
21. Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE. doi: 10.1126/stke.2392004re9
22. Kersse K, Verspurten J, Vanden Berghe T, Vandenabeele P (2011) The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci 36:541-552. doi: 10.1016/j.tibs.2011.06.006
23. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549-557. doi: 10.1038/21124
24. Xiao T, Towb P, Wasserman SA, Sprang SR (1999) Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99:545-555
25. Park HH, Logette E, Raunser S et al (2007) Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128:533-546. doi: 10.1016/j.cell.2007.01.019
26. Lin SC, Lo YC, Wu H (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885-890. doi: 10.1038/nature09121
27. Scott FL, Stec B, Pop C et al (2009) The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457:1019-1022. doi: 10.1038/nature07606
28. Wang L, Yang JK, Kabaleeswaran V et al (2010) The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol 17:1324-1329. doi: 10.1038/nsmb.1920
29. Wu B, Peisley A, Tetrault D et al (2014) Molecular Imprinting as a Signal-Activation Mechanism of the Viral RNA Sensor RIG-I. Mol Cell 55:511-523. doi: 10.1016/j.molcel.2014.06.010
30. Adrain C, Martin SJ (2001) The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26:390-397
31. Hong GS, Jung YK (2002) Caspase recruitment domain (CARD) as a bi-functional switch of caspase regulation and NF-kappaB signals. J Biochem Mol Biol 35:19-23
32. Jiang C, Lin X (2012) Regulation of NF-kappaB by the CARD proteins. Immunol Rev 246:141-153. doi: 10.1111/j.1600-065X.2012.01110.x
33. Kwon D, Yoon JH, Shin SY et al (2012) A comprehensive manually curated protein-protein interaction database for the Death Domain superfamily. Nucleic Acids Res 40:D331-D336. doi: 10.1093/nar/gkr1149
34. Bouchier-Hayes L, Martin SJ (2002) CARD games in apoptosis and immunity. EMBO Rep 3:616-621. doi: 10.1093/embo-reports/kvf139
35. Kufer TA, Sansonetti PJ (2011) NLR functions beyond pathogen recognition. Nat Immunol 12:121-128. doi: 10.1038/ni.1985
36. Rawlings DJ, Sommer K, Moreno-Garcia ME (2006) The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 6:799-812. doi: 10.1038/nri1944
37. Blonska M, Lin X (2011) NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res 21:55-70. doi: 10.1038/cr.2010.182
38. Lopez J, John SW, Tenev T et al (2011) CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol Cell 42:569-583. doi: 10.1016/j.molcel.2011.04.008
39. Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10:561-574. doi: 10.1038/nrc2889
40. Maelfait J, Beyaert R (2012) Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev 76:33-45. doi: 10.1128/MMBR.05012-11
41. O'Neill LA, Bowie AG (2011) The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 147:259-261. doi: 10.1016/j.cell.2011.09.027
42. Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210-215. doi: 10.1038/nri2725
43. Yuan S, Yu X, Asara JM, Heuser JE, Ludtke SJ, Akey CW (2011) The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 19:1084-1096. doi: 10.1016/j.str.2011.07.001
44. Bouchier-Hayes L, Green DR (2012) Caspase-2: the orphan caspase. Cell Death Differ 19:51-57. doi: 10.1038/cdd.2011.157
45. Moreira LO, Zamboni DS (2012) NOD1 and NOD2 signaling in infection and inflammation. Front Immunol 3:328. doi: 10.3389/fimmu.2012.00328
46. Thome M, Charton JE, Pelzer C, Hailfinger S (2010) Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2:a003004. doi: 10.1101/cshperspect.a003004
47. Woo HN, Hong GS, Jun JI et al (2004) Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein. FEBS Lett 578:239-244
48. Lee SH, Stehlik C, Reed JC (2001) Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 276:34495-34500. doi: 10.1074/jbc.M101415200
49. Lamkanfi M, Denecker G, Kalai M et al (2004) INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem 279:51729-51738. doi: 10.1074/jbc.M407891200
50. Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES (2001) Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ 8:649-657. doi: 10.1038/sj.cdd.4400881
51. Le HT, Harton JA (2013) Pyrin- and CARD-only proteins as regulators of NLR functions. Front Immunol 4:275. doi: 10.3389/fimmu.2013.00275
52. Koseki T, Inohara N, Chen S, Nunez G (1998) ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA 95:5156-5160
53. Nam YJ, Mani K, Ashton AW et al (2004) Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell 15:901-912. doi: 10.1016/j.molcel.2004.08.020
54. Dufner A, Pownall S, Mak TW (2006) Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci USA 103:988-993. doi: 10.1073/pnas.0510380103
55. Zhu S, Jackson R, Flavell RA (2014) The lock-washer: a reconciliation of the RIG-I activation models. Cell Res 24:645-646. doi: 10.1038/cr.2014.58
56. Park HH (2012) Structural features of caspase-activating complexes. Int J Mol Sci 13:4807-4818. doi: 10.3390/ijms13044807
57. Vande Walle L, Lamkanfi M (2011) Inflammasomes: caspase-1-activating platforms with critical roles in host defense. Front Microbiol 2:3. doi: 10.3389/fmicb.2011.00003
58. Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13:343-351. doi: 10.1038/ni.2224
59. Correa RG, Milutinovic S, Reed JC (2012) Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep 32:597-608. doi: 10.1042/BSR20120055
60. Hara H, Iizasa E, Nakaya M, Yoshida H (2010) L-CBM signaling in lymphocyte development and function. J Blood Med 1:93-104. doi: 10.2147/JBM.S9772
61. Thome M (2008) Multifunctional roles for MALT1 in T-cell activation. Nat Rev Immunol 8:495-500. doi: 10.1038/nri2338
62. Beug ST, Cheung HH, LaCasse EC, Korneluk RG (2012) Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol 33:535-545. doi: 10.1016/j.it.2012.06.004
63. Dueber EC, Schoeffler AJ, Lingel A et al (2011) Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334:376-380. doi: 10.1126/science.1207862
64. Reikine S, Nguyen JB, Modis Y (2014) Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front Immunol 5:342. doi: 10.3389/fimmu.2014.00342
65. Janssens S, Tinel A (2012) The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ 19:13-20. doi: 10.1038/cdd.2011.162
66. Vakifahmetoglu-Norberg H, Zhivotovsky B (2010) The unpredictable caspase-2: what can it do? Trends Cell Biol 20:150-159. doi: 10.1016/j.tcb.2009.12.006
67. de Alba E (2009) Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J Biol Chem 284:32932-32941. doi: 10.1074/jbc.M109.024273
68. Qiao Q, Yang C, Zheng C et al (2013) Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly. Mol Cell 51:766-779. doi: 10.1016/j.molcel.2013.08.032
69. Chou JJ, Matsuo H, Duan H, Wagner G (1998) Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94:171-180
70. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM (2000) ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103:99-111
71. Vaughn DE, Rodriguez J, Lazebnik Y, Joshua-Tor L (1999) Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. J Mol Biol 293:439-447. doi: 10.1006/jmbi.1999.3177
72. Chen KE, Richards AA, Caradoc-Davies TT et al (2013) The structure of the caspase recruitment domain of BinCARD reveals that all three cysteines can be oxidized. Acta Crystallogr D Biol Crystallogr 69:774-784. doi: 10.1107/S0907444913001558
73. Jin T, Huang M, Smith P, Jiang J, Xiao TS (2013) The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces. Acta Crystallogr Sect F 69:482-487. doi: 10.1107/S1744309113010075
74. Jang TH, Park JH, Park HH (2013) Novel disulfide bond-mediated dimerization of the CARD domain was revealed by the crystal structure of CARMA1 CARD. PLoS One 8:e79778. doi: 10.1371/journal.pone.0079778
75. Yan N, Chai J, Lee ES et al (2005) Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 437:831-837. doi: 10.1038/nature04002
76. Potter JA, Randall RE, Taylor GL (2008) Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain. BMC Struct Biol 8:11. doi: 10.1186/1472-6807-8-11
77. Jin T, Curry J, Smith P, Jiang J, Xiao TS (2013) Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1. Proteins 81:1266-1270. doi: 10.1002/prot.24287
78. Coussens NP, Mowers JC, McDonald C, Nunez G, Ramaswamy S (2007) Crystal structure of the Nod1 caspase activation and recruitment domain. Biochem Biophys Res Commun 353:1-5. doi: 10.1016/j.bbrc.2006.11.122
79. Peisley A, Wu B, Xu H, Chen ZJ, Hur S (2014) Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509:110-114. doi: 10.1038/nature13140
80. Kowalinski E, Lunardi T, McCarthy AA et al (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-435. doi: 10.1016/j.cell.2011.09.039
81. Ferrao R, Wu H (2012) Helical assembly in the death domain (DD) superfamily. Curr Opin Struct Biol 22:241-247. doi: 10.1016/j.sbi.2012.02.006
82. Srimathi T, Robbins SL, Dubas RL, Hasegawa M, Inohara N, Park YC (2008) Monomer/dimer transition of the caspase-recruitment domain of human Nod1. Biochemistry 47:1319-1325. doi: 10.1021/bi7016602
83. Liu S, Chen ZJ (2011) Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 21:6-21. doi: 10.1038/cr.2010.170
84. Ver Heul AM, Gakhar L, Piper RC, Subramanian R (2014) Crystal Structure of a Complex of NOD1 CARD and Ubiquitin. PLoS One 9:e104017. doi: 10.1371/journal.pone.0104017
85. Ver Heul AM, Fowler CA, Ramaswamy S, Piper RC (2013) Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2. J Biol Chem 288:6890-6902. doi: 10.1074/jbc.M112.413781
86. Gack MU, Shin YC, Joo CH et al (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. doi: 10.1038/nature05732
87. Huang S, Zhao L, Kim K, Lee DS, Hwang DH (2008) Inhibition of Nod2 signaling and target gene expression by curcumin. Mol Pharmacol 74:274-281. doi: 10.1124/mol.108.046169
88. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I (1998) The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273:33508-33516
89. Bielig H, Velder J, Saiai A et al (2010) Anti-inflammatory arene-chromium complexes acting as specific inhibitors of NOD2 signalling. ChemMedChem 5:2065-2071. doi: 10.1002/cmdc.201000320
90. Zhao L, Kwon MJ, Huang S et al (2007) Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J Biol Chem 282:11618-11628. doi: 10.1074/jbc.M608644200
91. Correa RG, Khan PM, Askari N et al (2011) Discovery and characterization of 2-aminobenzimidazole derivatives as selective NOD1 inhibitors. Chem Biol 18:825-832. doi: 10.1016/j.chembiol.2011.06.009
92. Magnuson G, Khan P, Yuan H et al (2010) High Throughput Screening Assays for NOD1 Inhibitors - Probe 2. Probe Reports from the NIH Molecular Libraries Program, Bethesda
93. Palacios-Rodriguez Y, Garcia-Lainez G, Sancho M, Gortat A, Orzaez M, Perez-Paya E (2011) Polypeptide modulators of caspase recruitment domain (CARD)-CARD-mediated protein-protein interactions. J Biol Chem 286:44457-44466. doi: 10.1074/jbc.M111.255364
94. Moreno L, Gatheral T (2013) Therapeutic targeting of NOD1 receptors. Br J Pharmacol 170:475-485. doi: 10.1111/bph.12300
95. Gatheral T, Reed DM, Moreno L et al (2012) A key role for the endothelium in NOD1 mediated vascular inflammation: comparison to TLR4 responses. PLoS One 7:e42386. doi: 10.1371/journal.pone.0042386
96. Rickard DJ, Sehon CA, Kasparcova V et al (2013) Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway. PLoS One 8:e69619. doi: 10.1371/journal.pone.0069619
97. Saiai A, Bielig H, Velder J et al (2012) Hydrophenalene-Cr(CO)(3) complexes as anti-inflammatory agents based on specific inhibition of NOD2 signalling: a SAR study. Medchemcomm 3:1377-1385. doi: 10.1039/C2md20221b
98. Jun JC, Cominelli F, Abbott DW (2013) RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol 94:927-932. doi: 10.1189/jlb.0213109
99. Tigno-Aranjuez JT, Asara JM, Abbott DW (2010) Inhibition of RIP2s tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 24:2666-2677. doi: 10.1101/gad.1964410
100. Fulda S (2012) Novel promising IAP antagonist on the horizon for clinical translation. J Med Chem 55:4099-4100. doi: 10.1021/jm300475b
101. Ndubaku C, Varfolomeev E, Wang L et al (2009) Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. ACS Chem Biol 4:557-566. doi: 10.1021/cb900083m
102. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG (2008) IAP-targeted therapies for cancer. Oncogene 27:6252-6275. doi: 10.1038/onc.2008.302
103. Gaither A, Porter D, Yao Y et al (2007) A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res 67:11493-11498. doi: 10.1158/0008-5472.CAN-07-5173
104. Varfolomeev E, Blankenship JW, Wayson SM et al (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131:669-681. doi: 10.1016/j.cell.2007.10.030
105. Vince JE, Wong WW, Khan N et al (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131:682-693. doi: 10.1016/j.cell.2007.10.037
106. Bai L, Chen W, Wang X, Ju W, Xu S, Lin Y (2009) Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells. J Cell Biochem 108:1125-1131. doi: 10.1002/jcb.22346
107. Park CM, Sun C, Olejniczak ET et al (2005) Non-peptidic small molecule inhibitors of XIAP. Bioorg Med Chem Lett 15:771-775. doi: 10.1016/j.bmcl.2004.11.010
108. Infante JR, Dees EC, Olszanski AJ et al (2014) Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol 32:3103-3110. doi: 10.1200/JCO.2013.52.3993
109. Brunckhorst MK, Lerner D, Wang S, Yu Q (2012) AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer. Cancer Biol Ther 13:804-811. doi: 10.4161/cbt.20563
110. Okuhira K, Ohoka N, Sai K et al (2011) Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. FEBS Lett 585:1147-1152. doi: 10.1016/j.febslet.2011.03.019
111. Swinney DC, Xu YZ, Scarafia LE et al (2002) A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 277:23573-23581. doi: 10.1074/jbc.M200842200
112. Vicent MJ, Perez-Paya E (2006) Poly-l-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine. J Med Chem 49:3763-3765. doi: 10.1021/jm060458x
113. Mondragon L, Galluzzi L, Mouhamad S et al (2009) A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis Int J Program Cell Death 14:182-190. doi: 10.1007/s10495-008-0310-x
114. Wannamaker W, Davies R, Namchuk M et al (2007) (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoy l)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 321:509-516. doi: 10.1124/jpet.106.111344
115. Boost KA, Hoegl S, Hofstetter C et al (2007) Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med 33:863-871. doi: 10.1007/s00134-007-0588-0
116. Kast RE (2008) Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. JOP 9:350-353
117. Pelegrin P, Surprenant A (2009) Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 28:2114-2127. doi: 10.1038/emboj.2009.163
118. Lamkanfi M, Mueller JL, Vitari AC et al (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187:61-70. doi: 10.1083/jcb.200903124
119. Coll RC, Robertson A, Butler M, Cooper M, O'Neill LA (2011) The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 6:e29539. doi: 10.1371/journal.pone.0029539
120. Thacker JD, Balin BJ, Appelt DM et al (2012) NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs. Antimicrob Agents Chemother 56:1921-1930. doi: 10.1128/AAC.06372-11